A range of rhodium(I) and iridium(I) complexes containing bidentate phosphine−pyrazolyl ligands of general formulas [M(R 2 PyP)(COD)]BPh 4 (R = Me, i Pr, Ph, M = Ir, 3b − 3d and M = Rh, 4b − 4d ), [Ir(R 2 PyP)(CO) 2 ]BPh 4 (R = Me, i Pr, 5b, 5c ), and [M(R 2 PyP)(CO)Cl] (R = Me, i Pr, Ph, M = Ir, 6b − 6d and M = Rh, 7b − 7d ) were successfully synthesized. A number of these complexes and their analogues with unsubstituted ligands are extremely active as catalysts for the intramolecular hydroamination of alkynes. The air-stable cationic iridium complexes containing 1,5-cyclooctadiene, COD, as co-ligands, [Ir(R 2 PyP)(COD)]BPh 4 (R = H, Me, i Pr, and Ph, 3a − 3d ), are efficient as catalysts for the cyclization of 4-pentyn-1-amine ( 8 ) to 2-methyl-1-pyrroline ( 9 ) with the turnover rate at 50% conversion ( N t ) of up to 3100 h -1, at 60 °C. The cationic iridium complexes containing carbonyl co-ligands, [Ir(R 2 PyP)(CO) 2 ]BPh 4 (R = H, Me, i Pr, 5a − 5c ), are moderately effective in catalyzing this reaction, and the neutral complexes [M(R 2 PyP)(CO)Cl] (M = Ir, 6a Ir, 7a ) are ineffective. Generally, an increase in steric bulk of the substituent R near the nitrogen donor leads to an improvement in catalytic performance of the resulting metal complexes.
No takes yet. Share an insight, caveat, or question.
Field et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: